REMICADE® is a prescription medication for adults living with active psoriatic arthritis.
REMICADE® is not right for everyone, and individual results may vary. Talk with your doctor to decide if REMICADE® may be right for you.
REMICADE® belongs to a class of biologic medications known as tumor necrosis factor (TNF)-alpha blockers.
REMICADE® blocks a protein in your immune system called
When you have a chronic condition like psoriatic arthritis, it is important to talk to your doctor about treatment goals. These goals may include symptom control, prevention of further damage to your joints, and improvement in skin symptoms.
IN A CLINICAL STUDY, WHEN GIVEN WITH OR WITHOUT A MEDICATION CALLED METHOTREXATE, REMICADE®:
JOINT SYMPTOMS |
Worked quickly to help relieve symptoms like joint pain, stiffness, and swelling of psoriatic arthritis—in as little as 2 weeks for some people. |
FURTHER JOINT DAMAGE |
Helped stop further joint damage caused by psoriatic arthritis. |
SKIN SYMPTOMS |
Provided improvement in skin symptoms, including plaque thickness, scaling, and redness. In one study, most people saw at least 75% clearer skin at Week 14. |
Individual results may vary.
For adults with active psoriatic arthritis
REMICADE® is given as an intravenous (IV) infusion by a healthcare professional through a needle placed in a vein in your arm.
Given over a period of
about 2 hours
3 starter doses at
Weeks 0, 2, and 6
After starter doses, 1 maintenance
dose is infused every 8 weeks
Your doctor will determine the right dosage of REMICADE® for you.
What should I know about serious side effects?
REMICADE® can lower your ability to fight infections. Serious and sometimes fatal events can occur. There have been reports of serious infections, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that have spread throughout the body or cause infections in certain areas. Lymphoma, including a fatal kind called hepatosplenic
What are the common side effects?
The most common side effects of REMICADE® include:
Infusion reactions can happen up to 2 hours after your infusion of REMICADE®. Symptoms of infusion reactions may include:
Tell your doctor about any side effect that bothers you or does not go away.
These are not all of the side effects with REMICADE®. Ask your doctor or pharmacist for more information.
Call your doctor for medical advice about side effects.
Janssen CarePath offers information on options that may be available to help you lower your out-of-pocket costs for REMICADE®.
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections which include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body or caused infections in certain areas (such as skin). Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.
Unusual cancers have been reported in children and teenage patients taking tumor necrosis factor (TNF) blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in male teenagers or young men with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase. You should discuss any concerns about your health and medical care with your doctor.
It is not known if REMICADE® is safe and effective in children under 6 years of age.
What should I tell my doctor before I take REMICADE®?
You should let your doctor know if you have or ever had any of the following:
Also tell your doctor if you:
What should I watch for and talk to my doctor about before or while taking REMICADE®?
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.
You should tell your doctor right away if you have any of the signs listed below:
The more common side effects of REMICADE® include respiratory infections (such as sinus infections and sore throat), headache, coughing and stomach pain.
Please read the full Prescribing Information and Medication Guide for REMICADE® and discuss any questions you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
cp-53017v3
REMICADE® is a prescription medication used to treat:
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Plaque Psoriasis
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections which include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body or caused infections in certain areas (such as skin). Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.
Unusual cancers have been reported in children and teenage patients taking tumor necrosis factor (TNF) blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in male teenagers or young men with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase. You should discuss any concerns about your health and medical care with your doctor.
It is not known if REMICADE® is safe and effective in children under 6 years of age.
What should I tell my doctor before I take REMICADE®?
You should let your doctor know if you have or ever had any of the following:
Also tell your doctor if you:
What should I watch for and talk to my doctor about before or while taking REMICADE®?
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.
You should tell your doctor right away if you have any of the signs listed below:
The more common side effects of REMICADE® include respiratory infections (such as sinus infections and sore throat), headache, coughing and stomach pain.
Please read the full Prescribing Information and Medication Guide for REMICADE® and discuss any questions you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
cp-53017v3
REMICADE® is a prescription medication used to treat:
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Plaque Psoriasis